ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹12,965 Cr | ₹12,668 Cr | ₹11,599 Cr | ₹10,634 Cr | ₹8,865 Cr |
What is the latest Revenue of ALKEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹12,965 Cr |
| Mar2024 | ₹12,668 Cr |
| Mar2023 | ₹11,599 Cr |
| Mar2022 | ₹10,634 Cr |
| Mar2021 | ₹8,865 Cr |
How is Revenue of ALKEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹12,965 Cr | 2.34 | |
| Mar2024 | ₹12,668 Cr | 9.21 | |
| Mar2023 | ₹11,599 Cr | 9.08 | |
| Mar2022 | ₹10,634 Cr | 19.96 | |
| Mar2021 | ₹8,865 Cr | - | |
Compare Revenue of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹68,200.1 Cr | -0.4% | 2.7% | 3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| CIPLA | ₹123,504.0 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.4% |
2.7% |
3.8% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses